Sheikh Zayed Institute for Pediatric Surgical Innovation, Children's National Hospital, Washington, District of Columbia, USA.
Department of Surgery, Asan Medical Center, Songpa-Gu, Seoul, South Korea.
Lasers Surg Med. 2022 Feb;54(2):305-310. doi: 10.1002/lsm.23470. Epub 2021 Sep 7.
Bile duct injury during laparoscopic cholecystectomy has an incidence rate of 1%-2% and commonly appears under conditions of severe inflammation, adhesion, or unexpected anatomical variations. Despite the difficulties and rising concerns of identifying bile duct during surgeries, surgeons do not have a specific modality to identify bile duct except intraoperative cholangiography. While no biliary-specific fluorescent dye exists for clinical use, our team has previously described the development of a preclinical biliary-specific dye, BL-760. Here, we present our study of laparoscopic cholecystectomy using the fluorescent dye in a swine model.
STUDY DESIGN/MATERIALS AND METHODS: With an approval from Institutional Animal Care and Use Committee, two 20-25 kg swine underwent laparoscopic abdominal surgery using a Food and Drug Administration-cleared fluorescent laparoscopic system. Images of the liver and gallbladder were taken both before and after intravenous injection of the novel fluorescent dye. The dye was dosed at 60 μg/kg and injected via the ear vein. The amount of time taken to visualize fluorescence in the biliary tract was measured. Fluorescent signal was observed after injection, and target-to-background ratio (TBR) of the biliary tract to surrounding cystic artery and liver parenchyma was measured.
Biliary tract visualization under fluorescent laparoscopy was achieved within 5 min after the dye injection without any adverse effects. Cystic duct and extrahepatic duct were clearly visualized and identified with TBR values of 2.19 and 2.32, respectively, whereas no fluorescent signal was detected in liver. Cystic duct and artery were successfully ligated by an endoscopic clip applier with the visual assistance of highlighted biliary tract images. Laparoscopic cholecystectomy was completed within 30 min in each case without any complications.
BL-760 is a novel preclinical fluorescent dye useful for intraoperative identification and visualization of biliary tract. Such fluorescent dye that is exclusively metabolized by liver and rapidly excreted into biliary tract would be beneficial for all types of hepato-biliary surgeries. With the validation of additional preclinical data, this novel dye has potential to be a valuable tool to prevent any iatrogenic biliary injuries and/or bile leaks during laparoscopic abdominal and liver surgeries.
腹腔镜胆囊切除术(LC)中胆管损伤的发生率为 1%-2%,常发生于严重炎症、粘连或意外解剖变异的情况下。尽管在手术中识别胆管存在困难和挑战,但外科医生除了术中胆管造影术(IOC)外,没有特定的方法来识别胆管。虽然目前尚无临床应用的胆管特异性荧光染料,但我们团队之前已开发出一种临床前胆管特异性染料 BL-760。在此,我们报告在猪模型中使用这种荧光染料进行 LC 的研究。
研究设计/材料与方法:在机构动物护理和使用委员会的批准下,两只 20-25kg 的猪接受了腹腔镜腹部手术,使用了经美国食品和药物管理局批准的荧光腹腔镜系统。在静脉注射新型荧光染料前后拍摄肝脏和胆囊的图像。该染料以 60μg/kg 的剂量经耳静脉给药。测量观察胆管荧光所需的时间。注射后观察荧光信号,并测量胆管与周围胆囊动脉和肝实质的靶标与背景比(TBR)。
在染料注射后 5 分钟内,荧光腹腔镜下实现了胆管可视化,无任何不良反应。清晰地观察到胆囊管和肝外胆管,并分别测量到 TBR 值为 2.19 和 2.32。而肝组织未检测到荧光信号。在高亮胆管图像的视觉辅助下,使用内镜夹闭器成功结扎了胆囊管和动脉。在每种情况下,LC 均在 30 分钟内完成,无任何并发症。
BL-760 是一种新型临床前荧光染料,可用于术中识别和可视化胆管。这种专门由肝脏代谢并迅速排入胆管的荧光染料,将有益于所有类型的肝胆手术。随着额外临床前数据的验证,这种新型染料有可能成为一种预防腹腔镜腹部和肝脏手术中任何医源性胆管损伤和/或胆漏的有价值工具。